Hi @wombat777
Drawing your attention to the fact that an FTO transaction at pre-clinical stage would be derisked for the other party by bisantrene's historical Phase 2 and 3 safety results at much higher doses. So there may be no exact comparables.
Probably you already said this, but it doesn't hurt to say it again.
Pillar 1 - FTO (new thread), page-435
-
- There are more pages in this discussion • 2,557 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.56 |
Change
-0.015(0.95%) |
Mkt cap ! $265.8M | |||
| Open | High | Low | Value | Volume |
| $1.61 | $1.63 | $1.56 | $160.1K | 100.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 222 | $1.56 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.60 | 500 | 1 |
View Market Depth
| Last trade - 16.10pm 14/08/2024 (20 minute delay) ? |
| RAC (ASX) Chart |